Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Erik Manting
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:developedBy |
cell-based cancer immunotherapies
|
| gptkbp:focusesOn |
immuno-oncology
|
| gptkbp:founded |
2002
|
| gptkbp:headquarters_location |
gptkb:Stockholm
|
| https://www.w3.org/2000/01/rdf-schema#label |
Immunicum
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:Nasdaq_First_North_Growth_Market
|
| gptkbp:mergedInto |
DCprime
|
| gptkbp:product_candidate |
ilixadencel
|
| gptkbp:website |
https://immunicum.com/
|
| gptkbp:bfsParent |
gptkb:HealthCap
|
| gptkbp:bfsLayer |
8
|